Cytokines in stress

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 1, 2005, Pages 1-5

  Di Giannantonio, M ^a   Frydas, S ^b   Kempuraj, D ^c   Karagouni, E ^d   Hatzistilianou, M ^b   Conti, C M V ^a   Boucher, W ^c   Papadopoulou, N ^a   Donelan, J ^c   Cao, J ^c   Madhappan, B ^c   Boscolo, P ^a   Petrarca, C ^a   Castellani, L ^a   Quartesan, R ^e   Doyle, R ^f   Ferro, F M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

^e UNIVERSITY OF PERUGIA   (Italy)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytokine; Inflammation; Stress

Indexed keywords

CATECHOLAMINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOGLOBULIN A; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MELATONIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROLACTIN; STAT1 PROTEIN; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

BRAIN INJURY; CELL DIFFERENTIATION; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; HEART MUSCLE REPERFUSION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; TISSUE INJURY;

EID: 20044376093     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800101     Document Type: Editorial

References (55)

1. Anisman H. and Z. Merali. 2003. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 35:2.
2. Mann D.L. 2003. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 65:81.
3. Dhabhar F.S. 2002. Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 16:785.
4. Steptoe A., N. Owen, S. Kunz-Ebrecht and V. Mohamed-Ali. 2002. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav. Immun. 16:774.
5. Elenkov I.J. and G.P. Chrousos. 2002. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 966:290.
6. Dunn A.J., J. Wang and T. Ando. 1999. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 461:117.
7. Connor T.J. and B.E, Leonard. 1998. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 62:583.
8. Licinio J. and M.L. Wong. 1999. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4:317.
9. Ottaviani E, A. Franchini and C. Franceschi. 1997. Pro-opiomelanocortin- derived peptides, cytokines, and nitric oxide in immune responses and stress: an evolutionary approach. Int. Rev. Cytol. 170:79.
10. Maes M., G. Kenis and M. Kubera. 2003. In humans, corticotropin releasing hormone antagonizes some of the negative immunoregulatory effects of serotonin. Neuroendocrinol. Lett. 24:420.
11. Jin Q., B.S. Jhun, S.H. Lee, J. Lee, Y. Pi, Y.H. Cho, H.H. Baik and I. Kang. 2004. Differential regulation of phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced oxidative stress in the kidney of young and old rats. Biochem. Biophys. Res. Commun. 315:555.
12. Nagata D., M. Mogi and K. Walsh. 2003. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 278:31000.
13. Barnes K., J.C. Ingram, O.H. Porras, L.F Barros, E.R. Hudson, L.G. Fryer, F. Foufelle, D. Carling, D.G. Hardie and S.A. Baldwin. 2002. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115:2433.
14. Frost R.A., G.J. Nystrom and C.H. Lang, 2004. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am. J. Physiol. Endocrinol. Metab. 286:809.
15. Hansen M.K., P. Taishi, Z. Chen and J.M. Krueger. 1998. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J. Neurosci. 18:2247.
16. O'Connor K.A., J.D. Johnson, M.K. Hansen, F.J.L. Wieseler, E. Maksimova, L.R. Watkins and S.F. Maier. 2003. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 991:123.
17. Paul R., U. Koedel, F. Winkler, B.C. Kieseier, A. Fontana, M. Kopf, H.P. Hartung and H.W. Pfister. 2003. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 126:1873.
18. Alheim K., Z. Chai, G. Fantuzzi, H. Hasanvan D, Malinowsky, E. Di Santo, P. Ghezzi, C.A. Dinarello and T. Bartfai. 1997. Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc. Natl. Acad. Sci. U S A. 94:2681.
19. Hayashi Y., I. Jikihara, T. Yagi, M. Fukumura, Y. Ohashi, Y. Ohta, H. Takagi and M. Maeda. 2001. Immunohistochemical investigation of caspase-1 and effect of caspase-1 inhibitor in delayed neuronal death after transient cerebral ischemia. Brain Res. 893:113.
20. Trembovler V., S. Abu-Raya and E. Shohami. 2003. Synergism between tumor necrosis factor-alpha and H2O2 enhances cell damage in rat PC12 cells. Neurosci. Lett. 353:115
21. Lee J., J.S. Shin, J.Y. Park, D. Kwon, S.J. Choi, S.J. Kim and I.H. Choi. 2003. p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes. J. Neurosci. Res. 74:884.
22. Gilles S., S. Zahler, U. Welsch, C.P. Sommerhoff and B.F. Becker. 2003. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc. Res. 60:608.
23. Lynch A.M., C. Walsh, A. Delaney, Y. Nolan, V.A. Campbell and M.A. Lynch. 2004. Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10 - a role for IL-1 beta? J. Neurochem. 88:635.
24. Ji S.Q., S. Neustrom, G.M. Willis and M.E. Spurlock. 1998. Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression. J. Interferon Cytokine Res. 18:879.
25. Chakrabarty A., M.M. Danley and S.M. LeVine. 2004. Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis. J. Neurosci. Res. 76:822.
26. Chiu J.J., P.L Lee., C.N. Chen, C.I. Lee, S.V. Chang, L.J. Chen, S.C. Lien, Y.C. Ko, S. Usami and S. Chien. 2004. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24:73.
27. 2: disparate effects on kinases, NF-kappaB, and cytokine expression. Am. J. Physiol. Cell Physiol. 286:683.
28. Yamawaki H., S. Lehoux and B.C. Berk. 2003. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 108:1619.
29. Chen E., E.B. Fisher, L.B. Bacharier and R.C. Strunk. 2003. Socioeconomic status, stress, and immune markers in adolescents with asthma. Psychosom. Med. 65:984.
30. Kim S. and H. Iwao. 2003. Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. J. Pharmacol. Sci. 91:177.
31. Takeda K., A. Matsuzawa, H. Nishitoh and H. Ichijo. 2003 Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct. Fund. 28:23.
32. Cowan K.J. and K.B. Storey. 2003. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206:1107.
33. Takeda K. and H. Ichijo. 2002. Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells 7:1099.
34. Grossi G., A. Perski, B. Evengard, V. Blomkvist and K. Orth-Gomer. 2003. Physiological correlates of burnout among women. J. Psychosom. Res. 55:309.
35. Cohen S., E. Frank, W.J. Doyle, D.P. Skoner, B.S. Rabin and J.M. Gwaltney Jr. 1998. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol. 17:214.
36. Elenkov I.J. and G.P. Chrousos. 1999. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol. Metab. 10:359.
37. Kempuraj D., J. Donelan, S. Frydas, T. Iezzi, P. Conti, W. Boucher, N.G. Papadoopoulou, B. Madhappan, L. Letourneau, G. Sabatino, G. Riccioni and T.C. Theoharides. 2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol. 17:103.
38. Cross M.L. 2004. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 17:127
39. Kempuraj D., B. Madhappan, R. Sheeladevi, M. Nazer, S. Christodoulou, J. Reginald, N. Suthinthirarajan and A. Namasivayam. 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol. 17:57.
40. 4 and serum amyloid A elicit opposite interleukin-8 and NF-κB responses via the common ALX receptor. Int. J. Immunopathol. Pharmacol. 17:145.
41. Pannellini T., M. Iezzi, E. Di Carlo, E. Eleuterio, A. Coletti, A. Modesti, S. Rosini, M. Neri and P. Musiani. 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 17:171.
42. + T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.
43. Hitoglou S., S. Frydas, M. Hatzistilianou, D. Gougoustamou, F. Conti and A. Kotsis. 2004. Response of ADA and its isoenzymes in mice infected by Trichinella spiralis and treated with mimosine. Int. J. Immunopathol. Pharmacol. 17:191.
44. Vojdani A., J.B. Pangborn, E. Vojdani and E.L. Cooper. 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16:189
45. Bogdanos D.P., M. Lenzi, M. Okamoto, E.I. Rigopoulou, P. Muratori, Y. Ma, L. Muratori, D. Tsantoulas, G. Mieli-Vergani, F.B. Bianchi and D. Vergani. 2004. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA b51. Int. J. Immunopathol. Pharmacol. 17:83.
46. Battistoni A., M. Ajello, S. Ammendola, F. Superti, G. Rotilio and P. Valenti. 2004. Involvement of reactive oxygen species in bacterial killing with in epithelial cells. Int. J. Immunopathol. Pharmacol. 17:71.
47. 4). Int. J. Immunopathol. Pharmacol. 16:99.
48. Santino I., A. Iori, M. Nicoletti, S. Valletta, C. Cimmino, G.L. Scoarughi, D. Santapaola, R. Sessa and M. del Piano. 2003. Prevalence of Borrelia burgdorferi sensu lato genomospecies and of the human granulocitic ehrlichiosis (HGE) agent in Ixodes ricinus ticks collected in the area of Monti Lepini, Italy. Int. J. Immunopathol. Pharmacol. 16:105
49. Kempuraj D., S. Frydas, K. Kandere, B. Madhappan, R. Letourneau, S. Christodoulou, W. Boucher, G. Riccioni, P. Conti and T. C. Theoharides. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
50. Camera E., S. Lisby, M.L. Dell'Anna, B. Santucci, R. Paganelli, O. Baadsgaard and M. Picardo. 2003. Mononuclear cell antioxidant pattern and skin reactivity to irritants. Int. J. Immunopathol. Pharmacol. 16:49.
51. Austen W.G. Jr., L. Kobzik, M.C. Carroll, H.B. Hechtman and F.D. Moore Jr. 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16:1.
52. Romano A., C. Mondino, M. Viola and P. Montuschi. 2003. Immediate allergic reactions to β-lactams: diagnosis and therapy. Int. J. Immunopathol. Pharmacol. 16:19.
53. Bruno G., F. Tega, A. Bruno, U. Graf, F. Corelli, R. Molfetta and M. Barucco. 2003. The role of substance P in the cerebral ischemia. Int. J. Immunopathol. Pharmacol. 16:67.
54. Guhad F.A. and J. Hau. 1996. Salivary IgA as a marker of social stress in rats. Neurosci. Lett. 216:137.
55. Esterling B.A., J.K. Kiecolt-Glaser, J.C. Bodnar and R. Glaser. 1994. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol. 13:291.